Dyadic International (DYAI) EPS (Basic) (2018 - 2026)
Dyadic International (DYAI) posted EPS (Basic) of -$0.05 for Q1 2026, down 21.25% sequentially from -$0.04 in Q4 2025, and up 20.89% YoY from -$0.04 in Q1 2025.
Dyadic International (DYAI) EPS (Basic) (2018 - 2026) Analysis & Trends
Dyadic International has reported EPS (Basic) for 9 years, with the latest figure at -$0.05 in Q1 2026.
- Quarterly EPS (Basic) rose 20.89% year-over-year to -$0.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.2 (down 3.87% YoY) and the FY2025 annual result came in at -$0.79, down 0.9% from the prior year.
- EPS (Basic) slipped to -$0.05 in Q1 2026 per DYAI's latest filing, from -$0.04 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.01 in Q3 2024 and troughed at -$0.26 in Q2 2022.
- A 5-year average of -$0.09 and a median of -$0.07 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) jumped 99.8% in 2022, then sank 775.51% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.08 in 2022, then increased by 9.41% to -$0.07 in 2023, then climbed by 25.02% to -$0.05 in 2024, then increased by 18.2% to -$0.04 in 2025, then declined by 21.25% to -$0.05 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.05, -$0.04, and -$0.06 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 0.18 |
| 10 | Dyadic International | 20.47 Mn | 20.47 Mn | - | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.01 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.09 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -0.09 |
| Jun 30, 2022 | -0.26 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.45 |
| Sep 30, 2021 | -0.56 |
| Jun 30, 2021 | -0.36 |